Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elanco's score of 41 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Elanco reported total carbon emissions of approximately 1,430,209,000 kg CO2e, comprising 145,020,000 kg CO2e from Scope 1, 170,239,000 kg CO2e from Scope 2, and 624,083,000 kg CO2e from Scope 3 emissions. This marks a significant commitment to transparency in their emissions reporting, as they disclose data across all three scopes. Elanco has set ambitious climate commitments, aiming for net-zero emissions across all scopes by 2050. They are currently committed to near-term targets as part of the Science Based Targets initiative (SBTi), demonstrating their dedication to aligning with global climate goals. Over the years, Elanco has made notable progress in reducing emissions. For instance, from 2019 to 2023, they decreased their Scope 1 and 2 emissions from approximately 535,282,000 kg CO2e to about 430,209,000 kg CO2e, reflecting a proactive approach to sustainability. Their emissions intensity has also improved, indicating a reduction in emissions relative to revenue. Elanco's ongoing efforts to mitigate climate impact underscore their role in the consumer durables sector, where they are actively working towards a more sustainable future.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.